MXPA00010755A - Deodorant compositions containing 1,2-hexanediol - Google Patents

Abstract

The present invention is directed to deodorant compositions, and methods of using such compositions, wherein the compositions comprise from about 0.1%to about 99.9%by weight of a deodorant active, fragrance or combination thereof, and from about 0.1%to about 99.9%by weight of a carrier comprising 1,2-hexanediol. The deodorant composition preferably further comprises a suitable gellant or structurant to provide the desired product form, including a deodorant gel solid stick. The 1, 2-hexanediol carrier is a highly effective coupling agent and is milder to the skin when applied topically to the axilla or other areas of the skin as compared to many other polyol-containing deodorantcompositions. The present invention also relates to the use of triclosan/triclocarban combinations for improved deodorant efficacy.

Description

DEODORANT COMPOSITIONS CONTAINING 1,2-HEXANODIOL FIELD OF THE INVENTION This invention relates to deodorant compositions comprising a deodorant active agent and a carrier comprising 1,2-hexanediol. This carrier is softer to the skin than many other polyol-containing carriers and is especially effective as a coupling agent for gelling systems containing silicone or other carriers. The compositions provide improved clarity and therefore include clear or translucent deodorant compositions.

BACKGROUND OF THE INVENTION Deodorant compositions are well known for use in the control of odors associated with human perspiration. These »bad smells develop from human perspiration mainly as a result of microbial interaction with sweat glandular secretions which then produces acrid fatty acids. The deodorant compositions contain antimicrobial agents to help control the microbial development that causes these bad odors, and / or may contain deodorant fragrances that help mask the sensitive perception of bad odors 5 Deodorant compositions in gel form are especially popular as a means to avoid or mask the bad odors arise from perspiration. These gel deodorizing compositions are typically in the form of a solid stick or soft solids and, like other deodorant products, are also applied topically to the armpit or other area of the skin. Gel deodorants typically contain a gelling agent or other structuring agent, a polar solvent to solubilize the gelling agent or other structuring agent, and a deodorant active agent such as, for example, an antimicrobial active, deodorant fragrance or other odor masking material. These compositions can be aqueous or anhydrous systems and typically contain a polar solvent to help solubilize the gelling agent or other structuring agent. Many of these compositions also contain diol or other polyhydric solvents such as, for example, aliphatic polyhydric alcohols having from 2 to 12 carbon atoms, common examples of which they include propylene glycol, etylene glycol, diethylene glycol, 1,2-propylene glycol, 1,3-propylene glycol, 1,3-butylene glycol (1,3-butane-diol), glycepine (1, 2, 3- tr ihydroxy propane), 2-met? l-2,4-pentane diol (hexylene glycol), 2-et? ll, 3-hexane-d? ol, 1, 2, 6-hexanotr? ol, and combinations of same. However, many deodorant compositions cause skin irritation when applied topically to the armpits or other sensitive areas of the skin. This irritation is attributed mainly to the diol or to the polyhydric solvents commonly used in these compositions. This p-irritation is especially problematic when the applied composition is an anhydrous system that contains higher concentrations of the polyhydropus carrier, and even more problematic in a small percentage of the population that is unusually sensitive to topical irritation by the polyol. It has now been found that deodorant compositions containing 1,2-hexanediol cause less skin irritation than many other deodorant compositions containing diol or other highly polar polyol solvents. It has also been found that 1,2-hexanod? ol is an excellent coupling agent that not only causes less irritation to the skin, but it can also be used at low concentrations than many other coupling agents that also results in reduced irritation of the skin. The solvent 1,2-hexanod ol is also very useful for formulating clear or translucent compositions. It has also been found that deodorant compositions containing a combination of triclosan and cyclocarbon provide the composition with improved deodorant efficiency. This combination of active agents can be used in any topical composition, including the compositions described herein. Therefore, it is an object of the present invention to provide a deodorant composition and a method for using this composition that is milder to the skin than other diol-containing compositions. A further object is to provide a composition that also has good skin feel characteristics during and after topical application and / or provides improved product clarity.

BRIEF DESCRIPTION OF THE INVENTION The present invention is directed to deodorant compositions comprising from about 0.1% to about 99.9% by weight of the deodorant active agent and from about 0.1% to about 99.9% by weight of a carrier comprising 1, 2- hexanod? ol. The compositions can be aqueous or anhydrous. Preferred embodiments comprise a suitable gelling agent or other structuring agent. The present invention is also directed to a method for controlling or inhibiting odors associated with human perspiration, the method comprising the step of applying to the axillary area of the skin of approximately 0.1 grams a about 2.0 grams of the deodorant composition defined herein, wherein the deodorant composition comprises about 0.1% to about 99.9% by weight of the deodorant active agent, deodorant fragrance or combinations thereof, and from about 0.1% to about 99.9 % by weight of a carrier comprising 1,2-hexanediol, or wherein the deodorant composition comprises a combination of tricarbonate and trisclosan.

It has now been found that the selection of 1,2-hexanedione as a solvent or coupling agent in a deodorant composition provides the composition with relatively improved performance relative to other polyol-containing deodorant compositions. In particular, 1,2-hexanedione has been found to be softer to the skin than many other similar solvents that contain polyol and is more effective as a coupling agent than many other diol-containing solvents commonly used and / or provided. improved product clarity. These compositions also provide improved performance in skin feel, aesthetics and / or product stability compared to many other polyol-containing deodorant compositions. It has also been found that the combination of triclosan and cyclocarbon when applied topically to the armpit or other area of the skin provides improved deodorant efficacy that is greater than the additional deodorant benefits that would otherwise be expected from this combination. The trilobal / t-carbon combination is effective to provide improved deodorant performance from the deodorant composition of the present invention, or when applying any other topical deodorant composition containing this active combination and which is otherwise suitable for application to human skin DETAILED DESCRIPTION The deodorant compositions of the present invention include deodorant compositions in the form of final product or intermediary and include product forms such as, for example, solids or gel sticks, soft solids or creams, lotions or other liquids, aerosol or pump sprays , etc. These deodorant compositions are intended for topical application to the armpit or other suitable areas of the skin, or are intended to be used as manufacturing intermediates in the manufacturing process of other forms of final deodorant product. The term "environmental conditions" in the in which sense it is used herein refers to the surrounding conditions at about a pressure atmosphere, at about 50% relative humidity, and at about 25 ° C.

The solubility parameters for the solvents or other materials described herein are determined by methods well known in the chemical field to establish the relative polar character of a solvent or other of these materials. A description of the solubility parameters and the means to determine them is described in C.D. Vaughan, "Solubility Effects in Product, Package, Penetration and Preservation" 103 Cosmetics and Toiletpes 47-69, October 1988; and C. D. Vaughan, "Using Solubility Parameters in Cosmetics Formulat ion", 36 J. Soc. Cosmetic Chemists 319.333, September / October 1988, whose descriptions are incorporated herein by reference. The term "volatile", in the sense in which it is used herein, refers to those materials that have a measurable vapor pressure at 25 ° C. These vapor pressures will typically vary from about 0.01 mmHg to about 6 mmHg, more typically from about 0.02 mmHg to about 1.5 mmHg and have an average boiling point at about 1 atm which is typically less than about 250 ° C, more typically less than approximately 235 ° C, at 1 atmosphere (atm) of pressure.

Unless otherwise specified, all percentages, parts and proportions as used herein are represented by weight of the total composition. All weights belong to the listed ingredients, are based on the active level and, therefore, do not include solvents or by-products that can be included in commercially available materials, unless otherwise specified. The deodorant compositions and methods of the present invention may comprise, consist of, or consist essentially of, the essential elements and limitations of the invention described herein, as well as any of the additional or optional ingredients, components or limitations described in I presented.

DEODORANT ACTIVE AND FRAGRANCE The deodorant compositions of the present invention comprise an active deodorant, fragrance or combination thereof at concentrations ranging from about 0.001% to about 50%, preferably from about 0.01% to about 20%, most preferably from approximately 0.1% to approximately %, even more preferably from about 0.1% to about 5%, by weight of the composition. These active deodorants and fragrances include any known deodorant or fragrance active agent or otherwise safe and effective, suitable for topical application to human skin. Unless otherwise specified, the term "active" in the sense in which it is used herein generally refers to deodorant active or fragrance, while the term "active deodorant agent" specifically refers to materials Topics that can prevent or eliminate odors that result from perspiration The term "fragrance" in the sense in which it is used in the present, specifically refers to any topical material that covers or masks the bad odors that result from perspiration , or that otherwise provides the composition with the desired perfume aroma.

A) Active Deodorant Deodorant active agents suitable for use in the anhydrous gel deodorant composition include any topical material that is known or otherwise effective to prevent or eliminate odors associated with perspiration. These deodorant active agents are typically antimicrobial agents (e.g., bactericides, fungicides), malodor absorbing material, or combinations thereof. Preferred deodorizing actives are antimicrobial agents, non-limiting examples of which include cetyl-methyl-ammonium bromide, cetyl-pyrimidinium chloride, benzethonium chloride, dusobutyl-1-phenoxy-ethoxy-1-dimethyl-benzyl chloride. -ammonium, N-laupl sarcosm sodium, N-palmethyl sarcosine sodium, lauroyl sarcosm, N-mipstoyl glycine, N-laupl potassium sarcosm, tmethyl ammonium chloride, sodium-aluminum chlorhydroxy lactate, tpethyl citrate, ammonium chloride tpcetilmet lyo, difen leter of 2, 4, 4 '-tr? chlor-2' -hydroxy (tpclosan), 3,4,4'-tr-chlorocarbanilide (trichlocarbon), diammoalkyl amides, such as, for example, hexadecyl amide L-lysine, heavy metal salts of citrate, salicylate, and pyroctose, especially zinc salts, and acids thereof, heavy metal salts of pipthione, especially zinc pipthione, zinc phenosulfate, farnesol, and combinations of the same The preferred deodorizing actives are tcclosan, trichlorocarbon, and combinations thereof, wherein the preferred concentration of either triclosan or trichlocarbon ranges from about 0.01% to about 1.0%, more preferably about 0.1% about 0.5%, still of greater preference from about 0.1% to about 0 3%, by weight of the composition, and wherein the total concentration of tpclosan and t-chlorocarbon when used together in a composition ranges from about 0.01% to about 20%, more preferably from about 0.2% to about 1.0%, still more preferably from about 0.2% about 0.6%, by weight of the composition. It has been found that the combination of these two active deodorants provides deodorant efficacy that exceeds the cumulative deodorizing efficacy that one could otherwise predict from that combination. The preferred combination of tcclosan and trichlocarbon is effective to provide improved deodorant performance from the deodorant compositions described herein, or from any known deodorant or topical composition containing this combination that is otherwise suitable for application to human skin. Therefore, the present invention is also directed to a method for controlling the malodour associated with human perspiration by topically applying the combination of tpclosan / trichlorocarbon described above, or any other suitable composition containing the combination of tpclosan / Tricarbonolysis described in the above, to the armpit or other area of the skin. From most of these deodorant compositions containing this combination, from about 0.1 grams to about 2.0 grams are applied per axilla of the deodorant composition, preferably once or twice a day, most preferably once a day. Other deodorant active agents include odor absorbing materials, such as, for example, carbonate and bicarbonate salts, which include carbonates and bicarbonates of alkali metal, ammonium and tet ra-alkylammonium. Sodium and potassium salts of these odor absorbing materials are preferred. Other deodorant active agents include malodor absorbing materials such as, for example, astringent metal salts, especially inorganic and organic salts of aluminum, zirconium and zinc, as well as mixtures thereof. Particularly preferred are aluminum and zirconium salts, for example; aluminum halides, aluminum chlorohydrate, aluminum hydroxyhalides, praise oxyhalides, zirconyl hydroxyhalides and mixtures thereof. Non-limiting examples of antiperspirant actives for use herein are described in U.S. Patent 5,429,816, the disclosure of which is incorporated herein by reference.

B) Fragrance Fragrances suitable for use in the deodorant composition of the present invention include any topical material that is known or otherwise effective for masking malodor associated with perspiration, or which otherwise provides the composition with desired perfume aroma. These fragrances include any perfume or perfume chemical compound suitable for topical application to the skin. The concentration of the fragrance in the deodorant composition must be effective to provide the desired aroma characteristics or to mask the bad smell, where the bad smell is inherently associated with the composition itself or is associated with the development of a bad smell of human perspiration. Also, the fragrance and all the carriers that accompany it should not impart excessive itching to the skin, especially to cracked or irritated skin, at the levels previously described. The fragrance will typically be in the form of more water-soluble perfumes that are solubilized in the anhydrous gel deodorant composition. The fragrances are made by those skilled in the art in a wide variety of fragrances and concentrations. Typical fragrances are described in Arctander, Perfume and Flavor Chemicals (Aroma Chemicals), Vol. I and II (1969); and Arctander, Perfume and Flavor Materials of Natural Origm (1960). U.S. Patent 4,322,308 and U.S. Patent 4,304,679, both incorporated herein by reference, describe fragrance components that generally include, but are not limited to: volatile phenolic substances (such as, for example, iso-amyl salicylate, benzyl salicylate, and thymus red oil), essential oils (such as for example. 1( geranium oil, patchouli oil, and petit flower oil); citrus oils; extracts and resins (such as for example, siamese resoid of benzoin and resmoid of opoponaco); "synthetic" oils (such as for example Bergamot 37 and 430, Geranium 76 and Pomeransol 314), aldehydes and ketones (such as, for example, naphthyl ketone of B-methyl, hydrocinnamic aldehyde of pt-butyl-A-methyl and cyclohexanone from pt-amyl); polycyclic compounds (such as, for example, coumarin and β-naphthyl methylether); esters (such as, for example, diethyl phthalate, phenylethyl phenylacetate, nonanol-da-1: 4). The fragrances also include esters and essential oils derived from floral materials and fruits, citrus oils, pure aldehydes, resmoids, notes of musk and other animals (for example, natural isolates of civet, castoreum and musk), balsams, etc. and alcohols (such as, for example, dimyrcetol, phenylethyl alcohol and tet rahidromuguol). Examples of these useful components in the fragrances herein include decyl aldehyde, undecyl aldehyde, undecylene aldehyde, laupco aldehyde, amyl cinnamic aldehyde, phenyl methyl glycidate, nonyl methyl acetaldehyde, mipstic aldehyde, nonalactone, nonyl aldehyde, aldehyde of octyl, undecalactone, hexyl-lactam aldehyde, benzaldehyde, vanillin, heliotropane, camphor, para-hydroxy f enolbutanone, tetrahydronaphthalene of 6-acetyl 1,1,3,4,4,6-hexamethyl, alpha-methyl-ionone, gamma-ionone methyl, and amyl-cyclohexanone, and mixtures of these components. Other suitable fragrances are those that mask or help to mask the odors associated with perspiration (hereinafter referred to as odor masking fragrances), some non-limiting examples thereof are described in U.S. Patent 5,554,588, the U.S. Pat. of the United States 4,278,658, United States Patent 5,501,805, and Patent Application EP 684 037 Al, all are hereby incorporated by reference in their entirety. Preferred odor masking fragrances are those having a Deodorizing Value of at least about 0.25, more preferably from about 0.25 to about 3.5, still more preferably from 0.9 to about 3.5, as measured by the Deodorant Value Test described in Patent application EP 684 037 A1. The fragrance for use herein may also contain solubilizers, diluents or solvents that are well known in the art. These materials are described in Arctander, Perfume and Flavor Chemicals (Aroma Chemicals), Vol. I and II (1969). These materials typically include dipropylene glycol, diethylene glycol, CI-C, alcohols, and benzyl alcohol.

Liquid Carrier The deodorant composition of the present invention comprises from about 0.1% to about 99.9% by weight of a liquid carrier comprising 1,2-hexanedione, preferably a liquid carrier comprising a combination of 1,2-hexanediol. ol and one or more other known or otherwise effective liquid carrier materials. The carrier is a liquid under ambient conditions and therefore includes liquid combinations of carrier or combinations of carrier liquids and dissolved carrier solids, with the condition of any combination thereof in liquid form under ambient conditions. The deodorant compositions of the present invention can be formulated as an aqueous or anhydrous composition. For an aqueous formulation, the deodorant compositions may further comprise from about 10% to about 75% by weight of water, preferably from about 10% to about 60% by weight of water, even more preferably from about 15% to about 50% by weight of water. For an anhydrous formulation, the deodorant compositions contain less than about 10%, more preferably less than about 3%, even more preferably less than about 1%, still more preferably less than about zero percent by weight of water. The concentration of 1,2-hexanedione in the deodorant composition of the present invention ranges from about 0.1% to about 99.9% by weight of the deodorant composition, but the specific concentrations of 1,2-hexanediol can vary greatly depending on variables such as for example: 1) the function to which 1,2-hexanedione will serve, 2) the desired product form, viscosity and hardness of the deodorant composition, 3) whether the deodorant composition is in a final form or intermediary, and 4) other formulation variables well known in chemical or formulation techniques. For most product forms, the concentration of 1,2-hexanedione in the Deodorant composition ranges from about 0.1% to about 70%, more preferably from about 1% to about 40%, even more preferably from about 5% to about 25% by weight of the composition. In addition to the 1,2-hexanedione carrier, the deodorant composition may further comprise one or more optional liquid carriers suitable for topical application and suitable for the desired product form. These other optional carriers include any known liquid carrier material or otherwise effective for use in deodorants or other topical compositions. In case the optional liquid carrier is not easily miscible or dispersible in any way., 2-hexanedione or other materials in the liquid carrier component, then other liquid carriers or coupling agents can be added to the composition to carry the 1,2-hexanedione and other non-miscible or non-dispersible materials (e.g. non-polar solvents) in a solution or dispersion. The concentration of all carrier liquids in the deodorant composition for most product forms, including deodorant gels or solid gel bars, typically it ranges from about 10% to about 90%, preferably from about 30% to about 70% by weight of the deodorant composition. In this context, the term "all carrier liquids" refers to the combination of 1,2-hexanedione and optional carrier liquids, including water if present. The optional liquid carriers for use in combination with 1,2-hexanedione in the deodorant composition include any polar or non-polar, volatile or non-volatile liquid carrier, containing silicone or containing fluorine, organic, topically safe and effective, with the condition that the resulting combination of the carrier materials form a solution or other homogeneous liquid or liquid dispersion at the selected processing temperature of the composition. Processing temperatures for deodorant compositions typically range from about 28 ° C to about 250 ° C, more typically from about 28 ° C to about 110 ° C and even more typically from about 28 ° C to about 100 ° C.

Optional liquid carriers include moderately ethoxylated ethers of fatty alcohols having from about 8 to about 30 carbon atoms, esters of polyhydric alcohols, fatty acid esters, polyethylene glycols having at least 8 ethoxylate groups, polypropylene glycols having at least 8 propoxylate groups and combinations thereof. Specific and non-limiting examples of these solvents include propylene glycol monoisostearate; PPG-3 mipstileter, PEG-8; 1,2, pentanediol, PPG-14 butylether, dimethyl isosorbide and combinations thereof. Optional liquid carriers include C 1 to C 20 monohydric alcohols, preferably C 2 to C 2 monohydric alcohols, dihydric alcohols or C 2 to C 1 polyhydpides other than 1,2-hexanedione, preferably dihydric or polyhydric alcohols of C 2 to C 20; alkyl ethers of all those alcohols (preferably C 1 -C 4 alkyl); and polyalkoxylated glycols such as propylene glycols and polyethylene glycols having from 2 to 7 alkoxylate repeating groups (e.g., ethoxylate or propoxylate; polyglycerols having from 2 to 6 glycerol repeat portions; derivatives and combinations thereof. Specific examples of these optional liquid carriers include propylene glycol; hexylene glycol, dipropylene glycol, propylene glycol, glycepne, ethanol, propylene glycol ether, dipropylene glycol methyl ether, dipropylene glycol, propylene glycol, ethanol, n-propanol, n-butanol, t-butanol, 2-methoxyethanol, 2-ethoxyethanol, andylene glycol, isopropanol, isobutanol, 1,4-butylene glycol, 2,3-butylene glycol, 2,4-d? hydroxyl-2-methylpentane, triethylene glycol, 1,3-butanedione, 1,4-butanedione and combinations thereof. Other similar solvents but suitable for use as optional liquid carriers are described, for example, in U.S. Patent 4,781,917 (Luebbe et al.), U.S. Patent 5,643,558 (Provancal et al.), U.S. Pat. United States 4,816,261 (Luebbe et al.), EP 404 533 Al (Smith et al.), The disclosures of which are incorporated herein by reference. Other optional liquid carriers include benzoate co-solvents, cinnamate esters, secondary alcohols, benzyl acetate, phenyl alkane and combinations thereof.

Preferred optional liquid carriers include PPG-3-methyl ester, dnsopropyl adipate, PPG-14-butyl ether, dimethicone copolyols and combinations thereof. Other optional liquid carriers include modified or organofunctional silicone carriers, such as, for example, polyalkylsiloxanes, polyalkylarylsiloxanes, polyestersiloxanes, polyethersiloxanes, in the form of copolymers, polyfluorosiloxanes, polyammosiloxanes and combinations thereof. These modified silicone carriers are typically liquid at ambient conditions and have a preferred viscosity of less than about 100., 000 centistokes, more preferably less than about 500 centistokes, even more preferably, from about 1 and about 50 centistokes, and still more preferably, between about 1 and about 20 centistokes. These modified silicone carriers are generally known in the chemical field, some examples of which are described in 1 Cosme t i cs, Sci en ce and Techn olgy 27-104 (M. Balsam and E. Sagarm ed. 1972); United States Patent No. 4,202,879, granted to Shelton on May 13, 1980; U.S. Patent No. 5,069,897, issued to Orr on December 3, 1991; which are incorporated here as a reference. Suitable modified silicone carriers include, but are not limited to: compounds or materials as defined above and which are generally characterized in the following manner: silicone polyethers or silicone glycols (eg, dimethicone copolyol); polyethers bonded to silicone alkyl (e.g., Goldschmidt EM-90 or EM-97), siloxane surfactants of a pendant / trapping / peme configuration, silicone surfactants of a tpsiloxane configuration and silicone surfactants of ABA block copolymers / alpha-omega (such as, for example, polyoxyalkylenes, full or ethoxylated polyoxyethylene, polyoxyethylene / polyoxypropylene or ethoxylated / propoxylated); silicone emollients substituted with aromatic groups (for example, phenyl, alpha-methyl stipule, stipule, methylphenyl, alkyl phenyl); silicone copolymers with other functional groups including: hydrogen, alkyl, methyl, ammo, tr lf luoropropyl, vmilo, alkoxy, aplaxyl, aryl, phenyl, styryl, polyethers, esters, carboxylic compounds; alkylmethylsiloxanes or silicone waxes (eg, hexyl, octyl, lauplo, cetyl, esteaplo); nonionic functional siloxane copolymers with silanol or trismethylsiloxy end groups; nonionic functional siloxanes with main structure groups which are linked with trisiloxane or methicone; nonionic silicone surfactants; tetraethoxysilane; tetramethoxysilane; hexametoxy silicone; oximetoxitrisiloxane; silicone emulsifiers; siloxane or silicone reams; alkyl silicone resins; polyoxyalkylene silicone resins; MQ resins such as those of Shiseido / Shin-etsu, for example Japanese Patent Publication JP86143760 or of Walker Chem. 6MBH (described in EP722970); alkoxysiloxanes; alkoxysilanes; methicones (polymethylalkylsiloxanes); and combinations thereof Non-limiting examples of suitable modified silicone carriers that are used in the deodorant compositions herein include the following modified silicones available from Don Corning: DC-556, Cosmetic Grade Fluid (phenyl trimethicone), DC-1784 Emulsion; DC-AF Emulsion; DC-1520-US Emulsion; DC-593 Fluid (Dimethicone [and] Tpmethylsiloxysilicate), DC-3225C Fluid (Cyclomomet icone [and] Dimethicone Copolyol); DC-1401 (Cyclomethicone [and] Dimethiconol); DC-5640 Powder; DC-Q2-5220 (Dimethicone Copolyol); DC Q2-5324 (Dimethicone Copolyol); DC-2501 Cosmetic Wax (Dimethicone Copolyol); DC-2502 Fluid (Cetil Dimethicone); DC-2503 Wax (Stearyl Dimethicone); DC-1731 Volatile Fluid (Caproil Tpmeticona); DC-1-3563 (Dimethiconal); DC-X2-1286 (Dimeticonol); DC-X2-1146A (Cyclomethicone [and] Dimet iconol); DC-7224 (Tpmethylsilyllamodimethicone); DC-X2-1318 Fluid (Cyclomethicone [y] Vmildimet icone); DC-QF1-3593A fluid (Trisyllysiloxysilicate) and combinations thereof. Other non-limiting examples of suitable modified silicone carriers that are used in the deodorant compositions herein include the following modified silicones available from General Electric: GE CF-1142 (Methylphenyl Siloxane Fluid); GE SF-1328; GE SF-1188 (Dimethicone Copolyol); GE SF-1188A and combinations thereof. Other non-limiting examples of suitable modified silicone carriers that are used in the deodorant compositions herein include the following modified silicones that are obtained from Goldschmidt: Abil EM-90 (emulsifier of silicone); Abil EM-97 (polyether siloxane); Tegomer H-Si 2111, H-Si 2311, A-Si 2120, A-Si 2320, C-Si 2141, C-Si 2341, E-Si 2130, E-Si 2330, V-Si 2150, V-Si 2550 , H-Si 6420, H-Si 6440, H-Si 6460 (Copolymers of Dimethicone Alpha-Omega) and combinations thereof. Other non-limiting examples of suitable modified silicone carriers that are used in the deodorant compositions include the following: Masil 756 from PPG Industries (Tetrabutoxypropyl Trisiloxane); Umsil SF-R (UPI dimethiconol); Olin Silicate Clod (Tr ís [t r -butoxy siloxy] methylsilane); silicone copolymer F-754 (dimethicone copolyol from SWS Silicones); and combinations thereof. The deodorant composition of the present invention preferably comprises a volatile silicone carrier in combination with 1,2-hexanediol. The concentration of the volatile silicone preferably ranges from about 10% to about 90%, more preferably from about 15% to about 65% by weight of the deodorant composition. These volatile silicone carriers can be cyclic, linear or branched chain silicones having the required volatility as defined herein. The non-limiting examples of suitable volatile silicones are described in Todd et al., "Volatile Silicone Fluids for Cosmetics", Cosmetics and Toiletpes, 91: 27-32 (1976), which is incorporated herein by reference. Among these volatile silicones, cyclic silicones having between about 3 and 7, more preferably, between about 4 to 5 silicon atoms are preferred. The most preferred are those that correspond to the general formula: wherein n is from about 3 to about 7, preferably from about 4 to about 5, more preferably is 5. These volatile cyclic silicones in general have a viscosity value of less than about 10 centistokes. All viscosity values described herein are measured or determined at ambient conditions unless otherwise specified. Suitable volatile silicones used herein include, but are not limited to: Cyclomethicone D-5 (commercially available from G. E. Silicones), Dow Corning 344 and Dow Corning 345 (available from Dow Corning Corp.); GE 7207; GE 7158 and Silicone Fluids SF-1202 and SF-1173 (obtained from General Electric Co.); SWS-03314, SWS-03400, F-222, F-223, F-250, F-251 (available from SWS Silicones Corp.); Volatile Silicones 7158, 7207, 7349 (available from Union Carbide); Masil SF-V (available from Mazer) and combinations thereof. Optional liquid carriers also include a non-volatile silicone carrier other than or in addition to the preferred modified silicone carriers described herein. The non-volatile silicone carriers are preferably linear silicones which include, but are not limited to, those corresponding to any of the following formulas: CH, where n is greater than or equal to 1 These linear silicone materials in general will have values of viscosity of up to about 100,000 centistokes, preferably less than about 500 centistokes, more preferably, of between about 1 and 200 centistokes, still more preferably, between about 1 and 50 centistokes, measured at ambient conditions. Examples of suitable linear and non-volatile silicones used in the deodorant compositions include, but are not limited to: Dow Corning 200, hexamethylldiscane, Rhodorsil Oils 70047 which is obtained from Rhone-Poulenc, SF Masil Fluid which is obtained from Mazer, Dow Corning 225, Dow Corning 1732, Dow Corning 5732, Dow Corning 5750 (obtained from Dow Corning Corp.); SF-96, SF-1066 and SF18 (350) as Silicone Fluids (from G.E. Silicones); Velvasil and Viscasil (available from General Electric Co.) and Silicone L-45, Silicone L-530, Silicone L-531 (available from Union Carbide) and Siloxane F-221 and Slicone Fluid S S-101 (from SWS Silicones). The deodorant composition preferably comprises a combination of volatile and non-volatile silicone materials, more preferably a combination of carrier liquids of volatile and non-volatile silicone. Non-limiting examples of suitable combinations of these materials silicone are described in U.S. Patent 5,156,834 (Beckmeyer et al.), the disclosure of which is incorporated herein by reference. Other optional liquid carriers include non-polar, volatile and non-volatile carriers, such as, for example, mineral oil, petrolatum, osohexadecane, isododecane, various other hydrocarbon oils and combinations thereof. In this context, the term "non-polar" refers to those solvents having a solubility parameter of less than 8.0 (cal / cm3) 0 5, preferably from about 5.0 (cal / cm3) 0 5 to less than 8.0 ( cal / cm3) 0 5, more preferably 6.0 (cal / cm3) 0 5 a Suitable volatile non-polar solvents are those solvents having the vapor pressure and the solubility parameters described above, which may also include hydrocarbons, esters, amides and ethers having the required vapor pressure and solubility parameter. Preferred are non-polar hydrocarbon solvents which may be cyclic, branched or chain configurations, more preferably branched chain hydrocarbons.

Preferred volatile non-polar solvents are branched chain hydrocarbons having the required vapor pressure and solubility parameter and having from about 4 to about 30 carbon atoms, preferably from about 4 to about 20 carbon atoms, of greater preference of about 6 to about 20 carbon atoms. Specific non-limiting examples of these non-polar volatile solvents include those available from Exxon Chemical Company, Baytown, Texas USA, such as Isopar M (C13-C14 isoparafilm), Isopar C (CT-CS Isoparaffin), Cg-Cg Isoparaffin ( Isopar E), Isopar G (C? N-11 Isoparaffin), Isopar L (Cu-C? 3 Isoparaffm) and Isopar H (C11-C12 Isoparaffin) Other non-limiting examples of suitable branched-chain hydrocarbons include Permethyl 99A (isododecane) Permethyl 102A (ísoeicosane), Permethyl 101A (isohexadecane) and combinations thereof. The Permethyl series are available from Preperse, Inc., South Plamfield, New Jersey, U.S.A. Other non-limiting examples of suitable branched chain hydrocarbons include petroleum distillates, such as, for example, those available from Phillips Chemical such as Soltrol 130, Soltrol 170, and those available from Shell such as Shell Sol 70, -71, and -2033. Non-limiting examples of other suitable non-polar volatile solvents include dibutyl adipate, dnsopropyl adipate, dodecane, octane, decane, and combinations thereof and the Norpar paraffin cell available from Exxon Chemical Company such as Norpar 12, -13 and -15. Still another example includes C11-C15 alkanes / cycloalkanes available from Exxon such as Exxsol D80. Other optional liquid carriers for use in combination with 1,2-hexanedione include luorochemicals such as fluorosurfactants, fluorotelemers, and fluoropolyethers, some examples of which are described in Cosmetics & Toiletpes, Usmg Fluopnated Compounds in Topical Preparat íons, Vol. 111, pages 47-62, (October 1996) which is incorporated herein by reference. More specific examples of these liquid carriers include, but are not limited to: per-fluoropolymer-isopropylether, per-fluoropropylether, fluoro-acrylamide telomer, fluorinated-amide surfactants, perfluorinated thiol surfactants. Other more specific examples include enunciative: polyperf luoroisopropylether available from Dupont Performance * Chemicals under the trade name Fluortress® PFPE oils, and the fluorosurfactant series from Dupont Performance Chemicals under the tradename Zonyl® Fluorosurfactants.

GELIFICANT The deodorant compositions of the present invention are preferably in the form of gel-solid deodorants and preferably comprise a gelling agent or other suitable structuring agent to provide the desired strength and application characteristics to the composition. The gelling or structuring concentrations preferably range from about 0.01% to about 20%, preferably from about 0.1% to about 10%, more preferably from about 1% to about 8%, still more preferably from about 3% to about 7%, by weight of the deodorant composition. Any known gelling or structuring agent can be used in the deodorant composition of the present invention with the proviso that the selected gelling agent or structurant can be melt and form a solution or other homogeneous liquid or liquid dispersion with the liquid carrier as defined herein at a processing temperature between about 50 ° C and 150 ° C, preferably between about 50 ° C and 120 ° C, greater preference between approximately 60 ° C and 100 ° C. The selected gelling agent or structurant must also provide the gel deodorant composition with the desired gel matrix and product hardness after formulation and at the end of processing. Preferred gelling agents or structurants are salts of fatty acids, wherein the fatty acid portion has from about 12 to about 40 carbon atoms, preferably from about 12 to about 22 carbon atoms, more preferably from about 16 to about 20 carbon atoms, still more preferably from about 18 carbon atoms. Salt-forming cations suitable for use with these gelling agents include metal salts such as alkali metals, for example, sodium and potassium, and alkaline earth metals, for example, magnesium and aluminum. Sodium and potassium salts are preferred, more preferably sodium stearate, sodium palmitate, potassium stearate, potassium palmitate, sodium m-stearate, aluminum monostearate, and combinations thereof. The most preferred is sodium stearate. Non-limiting examples of fatty acids suitable for producing the gelling agents or fatty acid structurants include acids, such as, for example, myristic, palmitic, stearic, oleic, lmoleic, linolenic, margapco and combinations thereof. These fatty acids are preferably derived from sources, such as, for example, coconut oil, beef tallow, lanolin, fish oil, beeswax, palm oil, peanut oil, olive oil, cottonseed oil. , soybean oil, corn oil, rapeseed oil, rosin acids, fats and other natural sources, or are derived by synthetic or semi-synthetic methods well known to those skilled in the art of formulation Other gelling or structuring Suitable include hydroxyacids, fatty acids, fatty acid esters and amides and fatty acid salts, hydroxy fatty acids, cholesterol materials, lanolmolic materials, and other amide gelling agents known to be used as gelling agents or that are otherwise described in detail hereinafter. Non-limiting examples of suitable fatty acid gelling agents or structurants include fatty acid and hydroxyacids or alpha hydroxyacids, having from about 10 to about 40 carbon atoms, examples of which include 12-hydroxy acid, acid 12- hydroxylacupco, 16-hydroxy hexadecane acid, behenic acid, euric acid, stearic acid, caustic acid, lauric acid, isostearic acid, combinations thereof, and salts thereof. Other non-limiting examples of suitable gelling agents or structurants suitable for use in the deodorant composition include those corresponding to the following formula: wherein Ri is 0R2 or NR2R3 or containing silicone; and R2 and R3 are hydrogen, or an alkyl, aplo, or aplaxyl radical that is linear or branched or cyclic and has from about 1 to about 22 carbon atoms; preferably from about 1 to about 18 carbon atoms. R2 and R3 may be either the same or different; however, preferably, at least one is a hydrogen atom. Among these gelling agents those selected from the group consisting of 12-hydroxy stearic acid, 12-hydroxy tearic acid methylester, 12-hydroxyesteapic acid ethyl ester, 12-hydroxystearic acid steapelester benzylester 12- hydroxy stearic acid are preferred. hydroxyesteapco, 12-hydroxyesteapco acid amide, 12-hydroxystearic acid isopropyl amide, 12-hydroxystearic acid butylamide, 12-hydroxyesteapic acid benzylamide, 12-hydroxystearic acid phenylamide, t-butylamide 12-hydroxyesteapic acid, cyclohexylamide of 12-hydroxystearic acid, 1-adamant? Lick of 12-hydroxystearic acid, 2-adamantyl of 12-hydroxystearic acid, dnsopropyl of 12-hydroxystearic acid, and mixtures thereof.

Non-limiting examples of amide gelling agents or structurants suitable for use in the deodorant composition include disulfide or branched monoamide gelling agents, monosubstituted or branched diamide gelling agents, triamide gelling agents and combinations thereof. Preferred are the alkylamides of di- and / or tribasic carboxylic acids or anhydrides corresponding to the formula: R, or R, I 'II I 5 -C -C -N -, -X -Y - Z - R, wherein a structure is formed from the bonding of C ', C "and X, and wherein: a) Ri is null, hydroxy, hydrogen, aryl, siloxane or aplo substituted with C? -C22 alkyl or alkyl ethers of C? -C22, C1-C22 alkylesters, C1-C22 alkoxy, C? -C22 alkenyl, C1-C22 alkyl, straight chain, cyclic or branched, substituted or unsubstituted, saturated or more saturated; preferably, C-C18-alkyl, C-C18-alkenyl, C-C18-alkoxy, C4-C18-alkylesters, C-C-8-alkyllethers or aplo substituted with C-C-8alkyl, more preferably, C12-C18alkyl, C? 2-C? 8 alkenyl, C12-C? alkoxy?, C? 2-C? b alkylesters, C12-C18 alkyl ethers or C12-C18 alkyl substituted aryl; b) R 2, R 4, R 5 and R together or independently are hydrogen, hydroxy, aplo, siloxane or substituted by C 1 -C 22 alkyl or C 1 -C 22 alkylethers, C 1 -C 22 alkylesters, C 1 -C 22 alkoxy, C?-C22 alkenyl, straight-chain, branched or cyclic C!-C22 alquilo alkyl, substituted or unsubstituted, saturated or unsaturated; preferably, C4-C10 alkyl, C4-C10 alkenyl, C4-C10 alkoxy, C4-C10 alkylester, C4-C10 alkyl ether or substituted by C4-C10 alkyl, more preferably C- alkyl- C8, C4-C8 alkenyl, C4-C8 alkoxy, C4-C8 alkylesters, C4-C8 alkyl ethers or aplo substituted with C-C8 alkyl; c) R3, is null, hydroxy, hydrogen, C1-C4 alkylethers or C1-C4 alkylesters, C1-C4 alkoxy, C1-C4 alkenyl, straight, branched or cyclic C1-C4 alkyl, substituted or unsubstituted, saturated or more saturated; preferably, C 1 -C 4 alkoxy, hydroxy or hydrogen, more preferably, a hydroxy or hydrogen, d) RT and Re independently or together are, null, hydrogen, hydroxy, aplo, siloxane or aryl substituted with C 1 -C 22 alkyl or alkylethers of C1-C22, C alqu-C22 alkylesters, C?-C22 alkoxy, C?-C22 alkenyl, straight-chain, branched or cyclic C? ~C 22 alkyl, substituted or unsubstituted, saturated or unsaturated, preferably, C4-C10 alkyl, C4-C10 alkenyl, C4-C10 alkoxy, C4-C10 alkylester, C4-C10 alkyl ether or anyl substituted with C4-C10 alkyl, more preferably C-C8 alkyl , C4-C8 alkenyl, C4-Ce alkoxy, C-C8 alkylesters, C4-C3 alkyl ethers or aplo substituted with C-C3 alkyl, e) R9 is null or hydrogen, f) Rio and R11 independently or together are, null, hydrogen, hydroxy, aplo, siloxane or aplo substituted with C? -C6 alkyl or Ci-Ce alkyl ethers, Ci-C? alkylesters, C? -C6 alkoxy, C? -C6 alkenyl, C? -C6 straight chain, branched or cyclic, substituted or unsubstituted, saturated or unsaturated, preferably C1-C4 alkyl, C1-C4 alkenyl, C1-C4 alkoxy, C1-C4 alkylester, C1- C4 alkylethers C4, aryl substituted with C 1 -C 4 alkyl or hydrogen, more preferably, a hydrogen, g) X is zero, nitrogen, aryl or + CH 2 -) - ", wherein n is an integer from 1 to 6, preferably, - CH2-n, where n is an integer from 1 to 3; h) Y is zero, acyl or carbonyl; i) Z is zero, hydrogen, hydroxy, aryl, siloxane, nitrogen or substituted by C 1 -C 22 alkylethers, or C 1 -C 22 alkylesters, C 1 -C 22 alkoxy, C 1 -C 22 alkenyl, C1-C22, straight-chain, branched or cyclic C1-C22 alkyl, substituted or unsubstituted, saturated or unsaturated; preferably, C4-C10 alkyl, C4-C10 alkenyl, C4-C10 alkoxy, C4-C10 alkylester, C4-C10 alkylethers or aplo substituted with C-C10 alkyl, more preferably alkyl, C4-C8, C4-C8 alkenyl, C-C8 alkoxy, C4-Cs alkylesters, C4-C8 alkylethers or aryl substituted with C4-C8 alkyl; and j) "a" is a double or simple link as long as. (1) when X is zero, Y, Z, R3, R7 and R8 are zero, C 'is directly bonded to C "and Ri is not a hydrogen; (n) when X and Z are not null and Y is zero, X is directly linked to Z; (m) when Z is zero, a hydrogen or a hydroxy, R and R8 are zero; and (? v) "a" is a double bond, R3 and R9 are null. Non-limiting examples of specific alkylamide gelling agents suitable for use in the deodorant composition include alkylamides of citric acid, t-carbalylic acid, aconitic acid, methyltriacetic acid, succimic acid and itaconic acid, for example 1,2,3-propane tributylamide. -h? drox? -l, 2, 3-propane tri-butyl amide, 1-propene-1, 2, 3-tr? oct? lam? da, N, N'N "-tr 1 (acetodecylamide) amine, 2 -dodecyl-N, N '-dihexyl-succinamide and 2-dodecyl-N, N'-dibutyl succinamide.

Optional Ingredients The deodorant compositions of the present invention may further comprise one or more optional components that may modify the physical, chemical, cosmetic or aesthetic characteristics of the compositions or may serve as additional "active" components when deposited on the skin. The compositions may also comprise optional inert ingredients. Many of these optional ingredients are known for use in deodorants, antiperspirants or other personal care compositions and may also be used in the deodorant compositions herein, provided that these optional materials are compatible with the essential materials described in present, or that otherwise do not unduly damage the performance of the product. Non-limiting examples of optional ingredients suitable for use in the deodorant compositions herein include pH adjusting agents, additional emollients; humectants; appeasing agents; dyes and pigments; medicines; sodium bicarbonate and related materials; preservatives and soothing agents such as, for example, aloe vera, alantoma, D-panthenol, avocado oil and other vegetable oils, and lichen extract.

SKIN IRRITATION It has been found that the deodorant compositions of the present invention, which contain 1,2-hexanedione, are less irritating to the skin than other similar compositions containing liquid polyols such as, for example, propylene glycol. To accentuate this benefit, the compositions described in Table 1 are evaluated for skin irritation in a patch test for three days. Potential irritation to the skin is measured by visual grading of skin erythema (redness) using qualified skin graders using a grading scale of 0 (no obvious skin irritation) to 4 (severe skin irritation). The data is reported as an average smaller squared average (average mark LS) of 22 panelists with statistical data.

Table 1 The data presented in Table 1 show that the compositions containing an active deodorant / anti-perspirant agent solubilized in 1,2-hexanediol are less irritating (statistically significant at 95% confidence) for the skin compositions containing an antiperspirant / deodorant active agent solubilized in propylene glycol.

MANUFACTURING METHOD The compositions of the present invention can be made by any of the methods known in the art for the formulation of the deodorant compositions, or which are otherwise effective in the formulation of these compositions. As will be apparent to those skilled in the art, the particular method will depend on the selection of the specific types and amounts of the components employed, as well as the desired final product form, for example, liquids, solid bars, soft solids, creams , lotions, systems in multiple or simple phase that contain a solid or dissolved active agent, suspensions or clear, translucent or opaque solutions, etc. In general, the deodorant compositions of the present invention can be prepared simply by combining the liquid carrier with the deodorant active agent. Optional gelling agents or structurants can be added with stirring and heating at a temperature between about 75 ° C and 100 ° C to allow the gelling agent or structurant to melt and form a virtually clear or translucent liquid. The resulting solution is cooled before adding the fragrance (if applicable) and then the cooled composition is emptied into a container or dispenser at about 70 ° C and allowed to solidify inside the container or distributor by cooling or allowing the composition contained at room temperature to cool. ambient METHOD OF USE The composition The deodorant of the present invention can be used as an intermediate in the formulation of other deodorant compositions or it can be formulated in a final form to be applied topically to the armpit or other area of the skin by any known or otherwise effective method to control the odor associated with perspiration. These methods comprise applying to the armpit or other area of the human skin a safe and effective amount of the deodorant composition of the present invention. In this context, the term "safe and effective amount" means an amount of the deodorant composition applied topically to the skin which is effective to avoid or mask by minimizing transpiration at the application site, while being safe for human use at a reasonable rate of benefit / benefit. In this context, a safe and effective amount typically ranges from about 0.1 grams per armpit to about 2.0 grams per armpit. The compositions are preferably applied to the armpit or other area of the skin once or twice a day, preferably once a day.

EXAMPLES The following Examples 1 to 8 illustrate specific embodiments of the deodorant compositions of the present invention, including methods of manufacture and use, although they are not intended to be limiting thereof. Other modifications may be attempted by the skilled artisan without departing from the spirit and scope of this invention. Each of the exemplified compositions is applied topically to the armpit in an amount effective to inhibit, prevent or mask the bad odor caused by perspiration in humans, typically in a varying amount of time. about 0.1 grams to about 2 grams per armpit. The applied compositions are effective to inhibit the development of bad odors or to mask the sensitive perception of these malodours as a result of the perspiration of the applied areas, and have good skin feel characteristics during and after application. The applied compositions are softer for the skin and cause little or no irritation to the skin. All exemplified amounts are weight percentages by weight based on the total weight of the composition unless otherwise specified. The deodorant compositions described in Table 2 are deodorant bars in aqueous gel, while the compositions described in Table 3 are anhydrous gel deodorant sticks.

Examples 1 to 3 Each of the compositions described in Table 2 are in the form of clear, translucent aqueous gel deodorant sticks that can be formulated by the conventional formulation methods described herein.

Table 2 Examples 4 to 8 Each of the compositions described below is in the form of anhydrous, clear or translucent gel deodorant sticks which can be formulated by the conventional formulation methods described herein.

Claims (12)

1. CLAIMS 1. A deodorant composition comprising: A) from 0.1% to 99.9% by weight of 1,2-hexanediol; and B) from 0.1% to 99.9% by weight of an active deodorant agent.
2. 2. The deodorant composition according to Claim 1, wherein the composition further comprises 0.01% to 20% by weight of a gellant wherein the gellant is a fatty acid salt having from 12 to 40 carbon atoms, preferably a metal salt of stearic acid.
3. 3. The deodorant composition according to Claim 1 or 2, wherein the deodorant active agent is selected from the group consisting of tpclosan, tclocloban and combinations thereof, preferably wherein the deodorant active agent is selected from the group consisting of 0.01% a 1.0% by weight of tpclosan, from 0.01% to 1.0% by weight of tcclocarbano and combinations thereof, more preferably where the deodorant active agent is a combination of 0 01% to 10% by weight of tpclosan and from 0.01% to 1.0% by weight of triclocarban.
4. 4. The deodorant composition according to any of the preceding claims, wherein the composition is an anhydrous system comprising less than 3% by weight of water.
5. 5. The deodorant composition according to any of the preceding claims, wherein the composition further comprises 0.01% to 15% by weight of a solvent in addition to 1,2-hexanedione, wherein the additional solvent is selected from the group consisting of Ci to C2o monohydric alcohols, polypropylene glycols having from 2 to 7 propoxylate repeating groups, polyethylene glycols having from 2 to 7 ethoxylate repeating groups, polyglycerols having from 2 to 6 repeating glycerol moieties, and combinations thereof.
6. 6 A method for controlling malodours associated with human perspiration, the method comprises the step of applying to an axillary area of the skin from 0 1 grams to 2.0 grams of a deodorant composition comprising: A) from 0.1% to 99.9% by weight of 1,2-hexanediol; and B) from 0.1% to 99.9% by weight of an active agent deodorant, fragrance or combination thereof.
7. 7. The method according to Claim 6, wherein the deodorant active agent is selected from the group consisting of tpclosan, tclocloban and combinations thereof, preferably wherein the deodorant active agent is selected from the group consisting of 0.01% to 1.0% by weight. tpclosan weight, from 0.01% to 1% by weight of tcclocarbano and combinations thereof, more preferably where the deodorant active agent is a combination of 0.01% to 10% by weight of tcclosan and from 0.01% to 1.0% by weight of triclocarbano.
8. 8. The method according to Claim 6 or 7, wherein the composition is an anhydrous system comprising less than 3% by weight of water.
9. 9. The method according to any of the Claims 6 to 8, wherein the composition further comprises 0.01% to 25% by weight of a solvent in addition to 1,2-hexanedione, wherein the additional solvent is selected from the group it consists of monohydric alcohols of Ci to C20, polypropylene glycols having from 2 to 7 propoxylate repeating groups, polyethylene glycols having from 2 to 7 ethoxylate repeating groups, polyglycerols having from 2 to 6 repeating glycerol moieties, and combinations of the same.
10. 10. A method for controlling malodours associated with perspiration by applying to the armpit or other area of the skin a deodorant composition comprising: A) from 0.01% to 1.0% by weight of tpclosan; and B) from 0.01% to 1.0% by weight of carbon tricarbonate.
11. 11. The method according to Claim 10 wherein the deodorant composition further comprises 1% to 40% by weight of 1,2-hexanedione.
12. 12. The method according to any of the Claims 6 to 11, wherein the deodorant composition further comprises 0 01% to 20% by weight of a gellant wherein the gellant is a fatty acid salt having from 12 to 40 carbon atoms, preferably a metal salt of stearic acid.